Comparison of Stent Strategies in Left Main Disease
Cuore Columbus, Milan, Italy; and New Tokyo Hospital, Chiba, Japan). The study population is described in Figure 1 . The decision to perform PCI instead of coronary artery bypass graft surgery was made after routine discussions between interventional cardiologists and cardiothoracic surgeons. Patients at high surgical risk, as defined by a European System for Cardiac Operative Risk Evaluation score of ≥6, and those who declined coronary artery bypass graft surgery were treated with PCI. All patients were informed about the alternative treatment options and the risks of PCI before being asked to provide written informed consent for the procedure. In all instances, patient preference for a specific procedure was taken into account. The relevant review boards in each institute approved the study protocol.
The characteristics of the ULM lesions, along with details of the PCI procedure, have been described previously. 9, 10 A true bifurcation lesion was defined as Medina class 1-1-1, 1-0-1, and 0-1-1. For the original procedure, a 1-SS was defined by the use of a single stent, regardless of lesion type, whereas a 2-SS procedure was defined by the use of 2 stents, regardless of the technique used. This definition included the use of any elective 2-SS, such as the minicrush, crush, culotte, simultaneous kissing stent, and V-stent, as well as scenarios where a second stent was necessary during a provisional T-stenting approach. In general, a 2-SS was selected when there was diffuse disease extending from the ostium of the LCx, whereas a 1-SS was preferred when there was only focal disease in this region.
The antiplatelet regimens were life-long low-dose aspirin (100 mg daily) and a thienopyridine (200-250-mg ticlopidine BID or 75-mg clopidogrel SID) for a minimum of 12 months after PCI. Clinical data were collected during a hospital visit or by telephone contact at 6-month intervals. Angiographic follow-up was scheduled between 6 and 12 months or earlier if clinically indicated (evidence of ischemia on noninvasive evaluation or if there was suspicion of ischemia on clinical presentation).
Death was considered to be of cardiac origin unless obvious noncardiac causes could be identified. Periprocedural myocardial infarction (MI) was defined as the presence of pathological and new Q waves on an ECG or an increase in the creatine kinase-myocardial band level to >3× the upper limit of the normal range. Spontaneous MI and stent thrombosis (ST) were defined according to the Academic Research Consortium definitions. 12 Target lesion revascularization (TLR) was defined as either PCI or coronary artery bypass graft surgery performed to treat ISR or ST of the target lesion, including the proximal and distal edge of the stent or the ostium of the SBs. TLR-MB was defined as treatment for ISR involving any LM segment from the LM ostium to the proximal left anterior descending artery, with or without SB involvement, and TLR-SB was defined as treatment for ISR involving the LCx alone. Chronic kidney disease was defined as an estimated glomerular filtration rate <60 mL/min per 1 
Study End Points
The study end points were major adverse cardiovascular events (MACE) during the follow-up period. MACE were defined as allcause death, MI, or TLR. Furthermore, the individual components of MACE, cardiac death, and TLR were also evaluated for MB-ISR.
Statistical Analysis
Continuous variables are expressed as means±SDs. Comparisons of clinical, echocardiographic, angiographic, or procedure-related characteristics were performed using the Student t test, Wilcoxon ranksum test (continuous variables), or χ 2 test (categorical), according to the stent strategy. Comparisons of event-free survival (Kaplan-Meier curves) were performed with the log-rank test. A propensity score indicating the predicted probability of receiving a specific treatment that was conditional on the observed covariates was calculated from the logistic equation for each patient. The following variables with P<0.20 on univariate analysis were included in the logistic regression model to calculate the propensity score: age, sex, hypertension, dyslipidemia, diabetes mellitus (DM), chronic kidney disease, ejection fraction, calcification, 3-vessel disease, true bifurcation, initial chronic total occlusion lesions, SYNTAX score, peripheral arterial disease, previous PCI, and use of an intra-aortic balloon pump. The C statistic was 0.75, and the Hosmer-Lemeshow test P value was 0.62. The individual propensity score was incorporated into the Cox proportional hazards regression models as a covariate with the treatment group as the variable of interest for the calculation of the adjusted hazard ratio. Furthermore, we performed rigorous adjustment for significant differences in the baseline characteristics of patients matched by propensity score. Clinical outcomes in the matched population were analyzed by Cox proportional hazards regression that were stratified for matched pairs. Furthermore, a subgroup analysis was performed in the second-generation DES group. The following variables with P<0.20 on univariate analysis in the second-generation DES group were included in the logistic regression model to calculate the propensity score: age, DM, chronic kidney disease, calcification, true bifurcation, initial chronic total occlusion lesions, SYNTAX score, and peripheral arterial disease. The C statistic was 0.62, and the Hosmer-Lemeshow test P value was 0.52. Results were reported as hazard ratio with associated 95% confidence intervals and P values. Analyses were conducted using IBM SPSS, version 21.0 (IBM SPSS Inc, Chicago, IL).
Results

Overall Population
During the study period, 937 consecutive patients with de novo UDLM disease were treated with first-generation (n = 689) or second-generation (n = 238) DES. Baseline clinical, lesion, and procedural characteristics of patients are shown in Tables 1 and 2 . Patients who were older, had DM, had previously undergone PCI or intravascular ultrasound
WHAT IS KNOWN
• Although 1-stent strategy (SS) is generally considered the default strategy for bifurcation lesions, there are some scenarios in which the 2-SS is initially necessary to guarantee the patency of both the main branch and side branch.
• The high occurrence of in-stent restenosis of the left circumflex artery ostium has been considered a major limitation of percutaneous coronary intervention for unprotected left main disease when using 2-SS.
WHAT THE STUDY ADDS
• The difference between 1-SS and 2-SS in the treatment of unprotected distal left main disease may be associated with the high development of side branch restenosis in 2-SS, which had little impact on longterm mortality.
• The difference decreased because of the advances in technology, functional assessments, and stent strategies.
• When necessary, a selective 2-SS can be justified and may be preferable in patients with unprotected distal left main disease provided optimal technique and intravascular imaging are used.
(IVUS)-guided PCI, and had full coverage of the ostial LM branch were more frequently observed in the 1-SS group, whereas patients with 3-vessel disease, untreated chronic total occlusion of the right coronary artery, true bifurcation, higher SYNTAX score, and who required intra-aortic balloon pump, kissing balloon inflation, and longer total stent length, were more frequently observed in the 2-SS group.
During hospitalization, 4 patients died (1 each from cerebral bleeding, abdominal aortic aneurysm rupture, access site bleeding, and subacute ST after gastric bleeding), and 50 of the 610 patients with available laboratory data had a periprocedural MI. The occurrence of periprocedural MI was significantly higher in the 2-SS group than in the 1-SS group (6.0% versus 11.9%; P=0.01). The median clinical follow-up was on day 1592 (interquartile range, 1127-2065). The 12-month follow-up was achieved in 98.9% of patients. At the 12-month follow-up, 90.5% of patients were still on dual antiplatelet therapy. Angiographic follow-up was conducted in 85.8% of patients.
Overall, 149 patients (15.9%) died, with cardiac death occurring in 70 (7.5%), during the follow-up period (Table I in the Data Supplement). There was no significant difference in the all-cause death rate between the 2 groups, but cardiac death tended to occur less frequently in the 2-SS group. MACE occurred in 306 (35.1%) patients, and it occurred at a higher rate in the 2-SS group than in the 1-SS group. However, this difference did not remain after the propensity score-adjusted analysis. Overall, TLR was performed in 188 (20.1%) patients, and it was performed in the 2-SS group more often. TLR-MB was performed in 81 (8.6%) of the TLR cases, but there was no significant difference in the incidence of TLR-MB between the 2 groups. In contrast, 139 patients (14.8%) underwent TLR-SB, with most SB restenoses (67.6%) being asymptomatic and detected by routine angiographic follow-up. TLR-SB was performed significantly more frequently in the 2-SS group than in the 1-SS group. There were no significant differences in the incidences of ST and MI. The clinical outcomes are summarized in Table 3 and Figure 2 . 
Subgroup Analysis of Patients Treated With SecondGeneration DES
Second-generation DES were used in 238 patients (1-SS, 154 patients; 2-SS, 84 patients). Baseline clinical and lesion characteristics in the second-generation DES group are available in Tables V and VI in the Data Supplement. During hospitalization, 6.3% of the patients sustained a periprocedural MI (5.8% in 1-SS and 7.1% in 2-SS; P=0.78). Clinical outcomes are summarized in Table 4 and Figure 4 . No significant differences in MACE, all-cause death, TLR, or TLR-MB were noted between the 2 groups. Furthermore, there was no significant difference in the incidence of TLR-SB between the 2 groups. After propensity score matching, 86 pairs were compared. Baseline clinical and lesional characteristics for the matched groups are summarized in Tables VII and VIII in the Data Supplement. Although cardiac death and MI were more frequently seen in the matched 1-SS group than in the 2-SS group, no significant differences in MACE, all-cause death, TLR, or TLR-MB were noted between the 2 groups (Table IX in the Data Supplement; Figure 5 ).
Discussion
The main findings of our study are as follows:
1. More complex lesions (true bifurcation, calcification, nontreated chronic total occlusion-right coronary artery, 3-vessel disease, high SYNTAX score, and more intra-aortic balloon pump usage) were observed in UDLM patients treated by the 2-SS compared with those treated by the 1-SS. In contrast, greater comorbidity (higher age, peripheral arterial disease, and DM) was associated with UDLM patients who received the 1-SS compared with the 2-SS. 2. Rates of cardiac death tended to be lower in UDLM patients treated with the 2-SS than in those treated with the 1-SS. Although this trend continued after adjustment for the propensity score, there was no difference in cardiac death between the 2 strategies in the propensity-matched pairs. 3. The occurrences of MACE and TLR were significantly higher in UDLM patients who received the 2-SS than in those who received the 1-SS, primarily because of TLR-SB. However, there were no differences in the TLR-MB and definite or probable ST between the 2 PCI strategies for UDLM disease. Early studies in the era of bare metal stents showed that using a 2-SS for UDLM disease was generally associated with poorer survival than a 1-SS. 2, 13 Even in the DES era, a 2-SS is still associated with a higher risk of cardiac mortality, ST, and the need for repeat revascularization because of lesion-specific problems and procedural complexity. [3] [4] [5] 8 However, the role of a 2-SS remains controversial in UDLM disease even when necessary because of diffuse disease extending from the ostium of the LCx artery. Notably, we demonstrated that the treatment of UDLM disease with a 2-SS was safe and feasible despite lesion complexity when compared with a 1-SS, with a low occurrence of definite or probable ST. There may be many reasons for this. First, 66.8% of the patients underwent IVUS-guided Data are presented as percentages and absolute numbers or means±SD, unless otherwise specified. 3VD indicates 3-vessel disease; CTO, chronic total occlusion; DES, drug-eluting stent; IABP, intra-aorta balloon pump; IVUS, intravascular ultra sound; LCx, left circumflex artery; RCA, right coronary artery; SYNTAX, Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery; and ULM, unprotected left main.
PCI for UDLM disease, which was a relatively higher percentage when compared with previous reports (21.7%-63.4%). [14] [15] [16] [17] [18] In PCI for UDLM disease, IVUS can help reduce unnecessary stent implantation and malposition, resulting in a decrease in ST and cardiac death.
14,16 de la Torre Hernandez et al 14 recently reported that performing IVUS-guided PCI for UDLM disease was advantageous when a 2-SS was selected. Furthermore, the minicrush was the most frequently used 2-SS procedure in this study. This procedure is similar to the double-kiss crush technique, which has been shown to have better cardiac mortality outcomes compared with other 2-SS procedures such as culotte, traditional crush, V-stenting, and simultaneous kissing stent. 19 In this study, kissing balloon inflation was performed in 94.5% of patients undergoing a 2-SS, which was crucial for successful outcomes in the approach, with evidence of prognostic value. 20 In this study, all patients were treated for UDLM disease in only 3 high-volume centers by experienced cardiovascular interventionists who routinely treated UDLM disease using a 2-SS and IVUS. Therefore, the low threshold for 2-SS in our institutes likely resulted in less severe comorbidities in the 2-SS group as a whole, resulting in an overall decrease in cardiac mortality. In contrast, for patients with worse comorbidities, such as older age, peripheral arterial disease, and DM, we may have had a higher threshold for the 2-SS because of the longer procedure and fluoroscopy times as well as higher contrast volumes, which are associated with complex procedures. Consequently, cardiac mortality in some ULM patients who had severe comorbidities with a 1-SS may have been worse compared with those who underwent a 2-SS because of the increased rates of severe comorbidities rather than the procedure itself. Another important point is that the high rate of TLR is a well-known limitation of LM branch stenting in any 2-SS. 3, 5, 8, 10 Our study results indicated that UDLM patients treated with 2-SS tended to have more complex lesions than those treated with 1-SS, resulting in a higher rate of repeat revascularizations. TLR was mainly driven by revascularization for LCx restenosis, with the TLR-SB rates for the 2-SSs exceeding 23% at 5 years. Angiographically, most restenoses at the ostial LCx artery were focal lesions for which there are several potential explanations. First, the ostial LCx has been reported to be the most common site of ISR because of the higher frequency of stent underexpansion when LM bifurcation lesions are treated with a 2-SS. However, restenosis still occurred in patients with optimal stent expansion, 21 so we assume that the LCx ostium itself must be associated with an increased risk of restenosis probably because of its hinge motion and wide angle, as we previously reported. 22 Furthermore, the minicrush technique that was predominantly used in our institutes was associated with a potential risk of geographic miss that may uncover an ostial LCx lesion and cause an increased risk of restenosis.
In contrast, the occurrence of TLR-MB remained similar between the 2 strategies, despite the inclusion of more complex lesions in the 2-SS group. Therefore, the difference between the use of a 1-SS and a 2-SS to treat UDLM disease might be summarized in the high development of SB restenosis. Furthermore, our group previously reported that SB-ISR had a lesser impact on long-term mortality compared with MB-ISR and that it was a largely asymptomatic and relatively benign phenomenon, especially when the LCx was small. 9 Thus, the higher occurrence of TLR in the 2-SS cases seemed to have a smaller clinical impact than expected.
Despite these conclusions, the patency of the LCx artery should be guaranteed to prevent hemodynamic collapse during PCI for UDLM disease. With the provisional 1-SS, there was a risk of acute SB compromise or occlusion during PCI, and the loss of a large SB vessel, such as the LCx artery, might lead to severe complications. 23 Furthermore, additional SB stenting has been reported to be necessary in approximately one third of UDLM patients after a 1-SS (16.9%-51.5%). Therefore, we suggest that a selective 2-SS can be justified when necessary and may be preferable in patients with UDLM disease, guaranteeing procedural safety. This concept has been more evident in the second-or third-generation DES era, as supported by our findings that there was no difference in the rates of either TLR or MACE between the 1-SS and 2-SS in patients treated with second-generation DESs. To prevent fatal adverse events, however, PCI for complex UDLM disease needs careful patient selection, a sophisticated strategy based on experience, and supplementation with adjuvant intravascular imaging modalities.
Study Limitations
The main limitations of this study were the lack of randomization and the retrospective, observational design. A randomized controlled trial dedicated to lesions in the UDLM bifurcation with a larger patient cohort and longer follow-up will be required to provide a better assessment of the advantages of 2-SSs. Furthermore, the limited follow-up period prevented us from recommending that 2-SSs were safe and effective after PCI for UDLM. However, it may be that the emergence of new DES technologies will further improve safety and efficacy outcomes in the treatment of ULM lesions.
Conclusions
The difference between the 1-SS and 2-SS in the treatment of UDLM disease might have been caused by the high development of SB restenosis in the latter strategy; however, overall, this had little impact on long-term mortality. Instead, the difference in TLRs likely decreased thanks to advances in technology, functional assessments, 26, 27 and stent strategies. It was notable that the treatment of UDLM was associated with a higher incidence of TLR when using a 2-SS than when using a 1-SS, probably because of restenosis of the ostium of the LCx. However, there was no difference in MACE or cardiac death between patients treated with the 2 strategies.
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